Back to available technologies

Blood-based biomarkers for colon cancer

Using multiplex ELISA techniques we are able to assay proteins in the plasma of patients with colorectal cancer to predict whether they will respond to the biological agents most commonly used to treat that disease.

Duke File (IDF) Number



  • Nixon, Andrew
  • Brady, Chris
  • Hatch, Ace
  • Hurwitz, Herbert
  • Jiang, Chen
  • Liu, Yingmiao
  • Owzar, Kouros
  • Sibley, Alex
  • Starr, Mark

For more information please contact


School of Medicine (SOM)

Interested in this Technology?

Submit your interest below.